about
Clathrin self-assembly involves coordinated weak interactions favorable for cellular regulationA step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsThe use of flow cytometry to assess a novel drug efficacy in multiple sclerosisCrystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.Structural requirements for interactions between leucine-sorting signals and clathrin-associated adaptor protein complex AP3Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivoMHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?Direct transport of newly synthesized HLA-DR from the trans-Golgi network to major histocompatibility complex class II containing compartments (MIICS) demonstrated using a novel tyrosine-sulfated chimeraNegative regulation by HLA-DO of MHC class II-restricted antigen processingPolarized expression of CD74 by gastric epithelial cells.Expression of xenogeneic MHC class II molecules in HLA-DR(+) and -DR(-) cells: influence of retrovirus vector design and cellular context.Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virionsPhagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.Cell-based vaccines for the stimulation of immunity to metastatic cancers.Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.Major histocompatibility complex class II antigen presentation in Hodgkin's disease.Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.Mechanisms and consequences of peptide selection by the I-Ak class II molecule.Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange.Stoichiometry of HLA class II-invariant chain oligomersMolecular control of steady-state dendritic cell maturation and immune homeostasis.Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) regionA retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoformPromoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationPhagocytic processing of antigens for presentation by class II major histocompatibility complex molecules.Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.Metastatic melanoma to the palatine tonsil with a favourable prognosis.Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages.Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system.The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expressionCompartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
P2860
Q24672270-11B93AC9-8327-454B-886F-38C0D7ED80FEQ26747063-260D12BE-DE5A-438C-B00E-C1924C492A0CQ26824619-D5775959-4561-434C-A5D7-4EF6D8FAA5B6Q27617244-C7CAD47B-51CB-400A-A7BB-89E32852D396Q28205970-BEC58E48-5F37-43DD-8C39-7CC669233DADQ28585501-A4E8393E-4530-4935-BD69-B3CFB6A4363AQ28594418-194D0C8A-7AE3-4422-BA44-8650241C99D2Q28611873-A5552C50-8A8A-4975-AF96-6B816DD0459AQ28613199-BCDD6C06-BB50-498D-A957-A8F01A4CCAEDQ30414247-56125148-13E3-4EC0-8050-57DB6C810787Q31042661-3BD8ABE2-C068-4544-9DAD-6B99EF2D32BCQ33206148-974CC43D-B0CE-46D7-991A-D00BBB3A2BE6Q33262483-AAA8CC51-D9CE-4880-9510-49942221E8BDQ33541540-C198DEAC-726C-4E7C-9D61-8B5B56ADDF68Q33641609-AD28D1B0-CBDE-47E6-9772-3252D2AEC1CEQ33649006-874B7921-E210-4BDE-856C-FF174D6DAA09Q33683408-FB6672F1-E8D0-42CB-9135-CB09B29256C9Q33776134-5A71B0F6-0018-41E3-AEA3-8834746609CCQ33779750-5EA32EBF-A3F0-4E6F-8D5F-702EB8A66D78Q33782440-F35CFCBC-348B-4EB8-AB17-446FBC908063Q33805040-87F58DF5-8350-417C-A040-0D4B7C608D4EQ33807088-7CFB652F-9E89-4E32-8D6A-13D346B134CEQ33815394-67288483-1C39-4D6A-9B30-F511639E8E9AQ33815430-9377B274-89C2-49D2-8033-C4268C73AA0FQ33815440-A44FFB37-35D6-441F-9D4F-F23CAE0FB156Q33834026-BBB24421-C8F7-4464-A97A-9D14BE93A163Q33882051-19882DDC-CE1E-42AE-A541-1C425CFA8832Q33887531-DAC446B1-866A-4B66-BFDF-E49852A6B923Q33905329-D8BCA249-8F89-4A5C-91C1-0C5795253584Q34086182-702CDAB6-A8B2-4180-966D-0C89C756520AQ34156238-DEA59D02-C01B-4B17-90DC-53279EAD1B2DQ34349848-FFEEC8FF-998A-4742-978E-1F08477E713DQ34352719-9AFEA6BA-F774-41A7-8155-31AE013D1101Q34491781-30909E1C-D703-49B1-95A2-B0C637FFA79DQ34982958-A9C5C63A-8E40-4E44-8788-A65D84C4A00EQ35585671-CB5BFC7E-71B8-4E30-B322-9FDB4FC5C30FQ35821240-06AAC797-EC6D-40FE-82F6-EC1D29DD5869Q35865718-E9DBF5B4-C5E4-455D-90A3-2674E532E01EQ36266489-F092A209-EB55-480D-876D-885161E6FAD2Q36266494-69E9D363-49B3-4313-8C1A-7DFC3741FCB2
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Invariant chain structure and MHC class II function.
@en
type
label
Invariant chain structure and MHC class II function.
@en
prefLabel
Invariant chain structure and MHC class II function.
@en
P1433
P1476
Invariant chain structure and MHC class II function.
@en
P2093
Cresswell P
P304
P356
10.1016/S0092-8674(00)81025-9
P407
P577
1996-02-01T00:00:00Z